The pharmacovigilance system master file shall have an Annex containing the following documents:
a list of medicinal products covered by the pharmacovigilance system master file, including the name of the medicinal product, the international non-proprietary name (INN) of the active substance(s), and the Member State(s) in which the authorisation is valid;
a list of written policies and procedures for the purpose of complying with Article 11(1);
the list of subcontracts referred to in Article 6(2);
a list of the tasks that have been delegated by the qualified person for pharmacovigilance;
a list of all scheduled and completed audits;
where applicable, a list of the performance indicators referred to in Article 9;
where applicable, a list of other pharmacovigilance system master files held by the same marketing authorisation holder;
a logbook containing the information referred to in Article 5(4).